| CF | Cystic Fibrosis |
| CF NBS | Cystic Fibrosis Newborn Bloodspot Screening |
| CF TDN | Cystic Fibrosis Therapeutics Development Network |
| CFTR | Cystic fibrosis transmembrane conductance regulator |
| CRMS/CFSPID | Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis |
| ECFS DNWG | European Cystic Fibrosis Society Diagnostic Network Working Group |
| HC | Healthy control |
| ICM | Intestinal Current Measurement |
| IRT | Immunoreactive Trypsin |
| IRT/DNA/EGA | Immunoreactive Trypsin Analysis/Analysis of genetic material, detection of variants in the CFTR gene/Genotypic analysis, identification of variants in the CFTR gene |
| ISC | Short circuit-current |
| NPD | Nasal Potential Difference |
| PBS | Phosphate-Buffered Saline |
| PI-CF | Cystic fibrosis with pancreatic insufficiency |
| PS-CF | Cystic fibrosis with pancreatic sufficiency |
| SOP | Standard operating procedure |
| VUC | Variant of unknown clinical significance |
| VVCC | Variant with varying clinical consequence |